Adiposogenital dystrophy: Difference between revisions
Kiran Singh (talk | contribs) No edit summary |
No edit summary |
||
Line 13: | Line 13: | ||
}} | }} | ||
'''For patient information, click [[Adiposogenital dystrophy (patient information)|here]]''' | '''For patient information, click [[Adiposogenital dystrophy (patient information)|here]]''' | ||
{{CMG}} [[Ogechukwu Hannah Nnabude, MD]] | |||
{{Adiposogenital_dystrophy}} | {{Adiposogenital_dystrophy}} | ||
{{GS}} | {{GS}} |
Revision as of 03:57, 18 August 2021
Adiposogenital dystrophy | |
ICD-10 | E23.6 |
---|---|
ICD-9 | 253.8 |
DiseasesDB | 29318 |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Ogechukwu Hannah Nnabude, MD
Adiposogenital dystrophy Microchapters |
Differentiating Adiposogenital dystrophy from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Adiposogenital dystrophy On the Web |
American Roentgen Ray Society Images of Adiposogenital dystrophy |
Risk calculators and risk factors for Adiposogenital dystrophy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2] Phone:617-632-7753
Synonyms and keywords:: Froehlich syndrome; frohlich syndrome; hypothalamic infantilism with obesity syndrome
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Adiposogenital dystrophy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Head X Ray | CT | MRI | Vision Test | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies